TwistPak: Mixing platform for swine vaccines brings convenience and flexibility
Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being
Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being
Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19
Cipla has reported consolidated financial results for the period ended March 31, 2022
The EBUS is designed to support the diagnosis and staging of various lung disorders
With the introduction of this device, Alkem is entering the core inhalation therapeutics and envisaging that the drug will reach the lungs effectively in each inhalation with added patient awareness and adherence programmes
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
CLNK is a biotechnology research and development company that utilizes umbilical cord blood as the raw material to develop innovative, allogeneic, off-the-shelf, cell based therapeutic products
Ultomiris showed early effect and lasting improvement in activities of daily living and has potential to reduce treatment burden with dosing every 8 weeks
Cysoni is a bionic device that paces the heart with real-time respiratory modulation
It enables precise visualization and treatment access to the left heart
Subscribe To Our Newsletter & Stay Updated